51 results
8-K
EX-10.1
bd5aoa7
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
424B5
2yugl s9ueqw07sk
26 Oct 23
Prospectus supplement for primary offering
4:55pm
PRE 14A
tqe7e
12 Apr 23
Preliminary proxy
4:07pm
S-3
5mxlfvaqslbvfw7
1 Jul 22
Shelf registration
5:01pm
S-3
EX-4.6
z7lvp2sbcijllr80sui
1 Jul 22
Shelf registration
5:01pm
S-3
EX-4.5
v0ipwhsu 2sw5hr
1 Jul 22
Shelf registration
5:01pm
DEF 14A
6yha74jex5bwuuikbv
27 Apr 22
Definitive proxy
4:10pm
10-K
lxhn l1z2l
29 Mar 22
Annual report
4:15pm
10-K
EX-4.2
ib4bp8j1y1vc4mp540n
29 Mar 22
Annual report
4:15pm
10-K
EX-10.20
stqbpgy wmdzypbg3q9i
29 Mar 22
Annual report
4:15pm
10-Q
n7cry c42hc15rsppkz
12 Aug 21
Quarterly report
4:22pm
8-K
EX-3.2
1v72lswwaql0kz3v
28 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:24pm
8-K
EX-3.1
ae5 edp5au30
28 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:24pm